104 related articles for article (PubMed ID: 15593421)
41. Antigenic and genetic analyses of foot-and-mouth disease virus type A isolates for selection of candidate vaccine strain reveals emergence of a variant virus that is responsible for most recent outbreaks in India.
Jangra RK; Tosh C; Sanyal A; Hemadri D; Bandyopadhyay SK
Virus Res; 2005 Sep; 112(1-2):52-9. PubMed ID: 16022900
[TBL] [Abstract][Full Text] [Related]
42. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
Li X; Liu R; Tang H; Jin M; Chen H; Qian P
Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351
[TBL] [Abstract][Full Text] [Related]
43. Novel chimeric foot-and-mouth disease virus-like particles harboring serotype O VP1 protect guinea pigs against challenge.
Li H; Li Z; Xie Y; Qin X; Qi X; Sun P; Bai X; Ma Y; Zhang Z
Vet Microbiol; 2016 Feb; 183():92-6. PubMed ID: 26790940
[TBL] [Abstract][Full Text] [Related]
44. Identification of a conformational epitope on the VP1 G-H Loop of type Asia1 foot-and-mouth disease virus defined by a protective monoclonal antibody.
Wang H; Zhao L; Li W; Zhou G; Yu L
Vet Microbiol; 2011 Mar; 148(2-4):189-99. PubMed ID: 20961714
[TBL] [Abstract][Full Text] [Related]
45. Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motif.
Brown F; Benkirane N; Limal D; Halimi H; Newman JF; Van Regenmortel MH; Briand JP; Muller S
Vaccine; 1999 Aug; 18(1-2):50-6. PubMed ID: 10501234
[TBL] [Abstract][Full Text] [Related]
46. Production and characterization of two serotype independent monoclonal antibodies against foot-and-mouth disease virus.
Yang M; Clavijo A; Suarez-Banmann R; Avalo R
Vet Immunol Immunopathol; 2007 Jan; 115(1-2):126-34. PubMed ID: 17109972
[TBL] [Abstract][Full Text] [Related]
47. Molecular investigation of foot-and-mouth disease virus circulating in Pakistan during 2014-17.
Ali W; Habib M; Khan RSA; Zia MA; Farooq M; Sajid S; Shah MSUD
Arch Virol; 2018 Jul; 163(7):1733-1743. PubMed ID: 29516248
[TBL] [Abstract][Full Text] [Related]
48. [Diversity of receptor recognition site of type Asial foot-and-mouth disease virus].
Li P; Bai X; Sun P; Lu Z; Cao W; Wu R; Yin H; Liu Z
Wei Sheng Wu Xue Bao; 2011 Mar; 51(3):423-8. PubMed ID: 21604558
[TBL] [Abstract][Full Text] [Related]
49. Recombinant bivalent vaccine against foot-and-mouth disease virus serotype O/A infection in guinea pig.
Yi JZ; Liu MQ; Zhu CZ; Zhang Q; Sheng ZT; Du QY; Yan WY; Zheng ZX
Acta Biochim Biophys Sin (Shanghai); 2004 Sep; 36(9):589-96. PubMed ID: 15346195
[TBL] [Abstract][Full Text] [Related]
50. Rescue of infective virus from a genome-length cDNA clone of the FMDV serotype O (IND-R2/75) vaccine strain and its characterization.
Rajasekhar R; Hosamani M; Basagoudanavar SH; Sreenivasa BP; Tamil Selvan RP; Saravanan P; Venkataramanan R
Res Vet Sci; 2013 Aug; 95(1):291-7. PubMed ID: 23465777
[TBL] [Abstract][Full Text] [Related]
51. Selection and characterization of an acid-resistant mutant of serotype O foot-and-mouth disease virus.
Liang T; Yang D; Liu M; Sun C; Wang F; Wang J; Wang H; Song S; Zhou G; Yu L
Arch Virol; 2014 Apr; 159(4):657-67. PubMed ID: 24122111
[TBL] [Abstract][Full Text] [Related]
52. The rescue and evaluation of FLAG and HIS epitope-tagged Asia 1 type foot-and-mouth disease viruses.
Yang B; Yang F; Zhang Y; Liu H; Jin Y; Cao W; Zhu Z; Zheng H; Yin H
Virus Res; 2016 Feb; 213():246-254. PubMed ID: 26732485
[TBL] [Abstract][Full Text] [Related]
53. [Molecular design and immunogenicity of a multiple-epitope foot-and-mouth disease virus antigen, adjuvants, and DNA vaccination].
Ma M; Jin N; Yin G; Lu H; Li C; Jin K; Qu Z
Sheng Wu Gong Cheng Xue Bao; 2009 Apr; 25(4):514-9. PubMed ID: 19637624
[TBL] [Abstract][Full Text] [Related]
54. Marker vaccine potential of foot-and-mouth disease virus with large deletion in the non-structural proteins 3A and 3B.
Biswal JK; Subramaniam S; Ranjan R; Sharma GK; Misri J; Pattnaik B
Biologicals; 2015 Nov; 43(6):504-11. PubMed ID: 26260689
[TBL] [Abstract][Full Text] [Related]
55. Host cell selection of antigenic variants of foot-and-mouth disease virus.
Bolwell C; Brown AL; Barnett PV; Campbell RO; Clarke BE; Parry NR; Ouldridge EJ; Brown F; Rowlands DJ
J Gen Virol; 1989 Jan; 70 ( Pt 1)():45-57. PubMed ID: 2471782
[TBL] [Abstract][Full Text] [Related]
56. Identification of a serotype-independent linear epitope of foot-and-mouth disease virus.
Yang B; Wang M; Liu W; Xu Z; Wang H; Yang D; Ma W; Zhou G; Yu L
Arch Virol; 2017 Dec; 162(12):3875-3880. PubMed ID: 28884236
[TBL] [Abstract][Full Text] [Related]
57. Genetic basis of antigenic variation in foot-and-mouth disease serotype A viruses from the Middle East.
Upadhyaya S; Ayelet G; Paul G; King DP; Paton DJ; Mahapatra M
Vaccine; 2014 Jan; 32(5):631-8. PubMed ID: 24035435
[TBL] [Abstract][Full Text] [Related]
58. Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle.
Sreenivasa BP; Mohapatra JK; Pauszek SJ; Koster M; Dhanya VC; Tamil Selvan RP; Hosamani M; Saravanan P; Basagoudanavar SH; de Los Santos T; Venkataramanan R; Rodriguez LL; Grubman MJ
Vet Microbiol; 2017 May; 203():196-201. PubMed ID: 28619144
[TBL] [Abstract][Full Text] [Related]
59. Identification of a conserved linear epitope on the VP1 protein of serotype O foot-and-mouth disease virus by neutralising monoclonal antibody 8E8.
Yang D; Zhang C; Zhao L; Zhou G; Wang H; Yu L
Virus Res; 2011 Jan; 155(1):291-9. PubMed ID: 20974198
[TBL] [Abstract][Full Text] [Related]
60. Genetic characterization of type A foot-and-mouth disease virus 3A region in context of the reemergence of VP359-deletion lineage in India.
Mohapatra JK; Sahu A; Pandey L; Sanyal A; Hemadri D; Pattnaik B
Infect Genet Evol; 2009 Jul; 9(4):483-92. PubMed ID: 19460313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
